Terms: = Bone cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Clinical Outcome
9 results:
1. Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.
Kemps PG; Zondag TCE; Arnardóttir HB; Solleveld-Westerink N; Borst J; Steenwijk EC; van Egmond D; Swennenhuis JF; Stelloo E; Trambusti I; Verdijk RM; van Noesel CJM; Cleven AHG; Scheijde-Vermeulen MA; Koudijs MJ; Krsková L; Hawkins C; Egeler RM; Brok J; von Bahr Greenwood T; Svojgr K; Beishuizen A; van Laar JAM; Pötschger U; Hutter C; Sieni E; Minkov M; Abla O; van Wezel T; van den Bos C; van Halteren AGS
Blood Adv; 2023 Feb; 7(4):664-679. PubMed ID: 36083130
[TBL] [Abstract] [Full Text] [Related]
2. High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia.
Wu L; Xia M; Sun X; Han X; Zu Y; Jabbour EJ; You MJ; Lin P; Li S; Xu J; Han H; Bueso-Ramos CE; Medeiros LJ; Qiu X; Yin CC
Eur J Haematol; 2020 Oct; 105(4):449-459. PubMed ID: 32535947
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study.
Rogers HJ; Wang X; Xie Y; Davis AR; Thakral B; Wang SA; Borthakur G; Cantu MD; Margolskee EM; Philip JKS; Sukhanova M; Bagg A; Bueso-Ramos CE; Orazi A; Arber DA; Hsi ED; Hasserjian RP
Am J Hematol; 2020 Jul; 95(7):799-808. PubMed ID: 32249963
[TBL] [Abstract] [Full Text] [Related]
4. The Atypical Receptor CCRL2 Is Essential for Lung cancer Immune Surveillance.
Del Prete A; Sozio F; Schioppa T; Ponzetta A; Vermi W; Calza S; Bugatti M; Salvi V; Bernardini G; Benvenuti F; Vecchi A; Bottazzi B; Mantovani A; Sozzani S
Cancer Immunol Res; 2019 Nov; 7(11):1775-1788. PubMed ID: 31484658
[TBL] [Abstract] [Full Text] [Related]
5. Low PD-1 Expression in Cytotoxic CD8
Mazzaschi G; Madeddu D; Falco A; Bocchialini G; Goldoni M; Sogni F; Armani G; Lagrasta CA; Lorusso B; Mangiaracina C; Vilella R; Frati C; Alfieri R; Ampollini L; Veneziani M; Silini EM; Ardizzoni A; Urbanek K; Aversa F; Quaini F; Tiseo M
Clin Cancer Res; 2018 Jan; 24(2):407-419. PubMed ID: 29074606
[No Abstract] [Full Text] [Related]
6. The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma.
Skalova A; Sar A; Laco J; Metelkova A; Miesbauerova M; Steiner P; Švajdler M; Michal M
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):140-146. PubMed ID: 27258560
[TBL] [Abstract] [Full Text] [Related]
7. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; Shoji M; Murata T
Int J Oncol; 2016 Aug; 49(2):812-22. PubMed ID: 27221776
[TBL] [Abstract] [Full Text] [Related]
8. Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Churi CR; Shroff R; Wang Y; Rashid A; Kang HC; Weatherly J; Zuo M; Zinner R; Hong D; Meric-Bernstam F; Janku F; Crane CH; Mishra L; Vauthey JN; Wolff RA; Mills G; Javle M
PLoS One; 2014; 9(12):e115383. PubMed ID: 25536104
[TBL] [Abstract] [Full Text] [Related]
9. Combined point mutation in kras or EGFR genes and EML4-ALK translocation in lung cancer patients.
Jürgens J; Engel-Riedel W; Prickartz A; Ludwig C; Schildgen O; Tillmann RL; Stoelben E; Brockmann M; Schildgen V
Future Oncol; 2014 Mar; 10(4):529-32. PubMed ID: 24754584
[TBL] [Abstract] [Full Text] [Related]
